All About Cardiovascular System and Disorders

MARCH 20, 2024

The most important advantage of laser angioplasty or excimer laser angioplasty, is that you need only a standard guidwire, 0.014 inch standard guide wire, unlike the other atherectomy devices which require a bulkier guidewire. Diagrammatic representation of laser angioplasty or atherectomy. One is in-stent restenosis.

Angioplasty 52

Angioplasty Plaque Stent Stents 52

American College of Cardiology

JUNE 20, 2024

The goal of the ULTIMATE III trial was to evaluate intravascular ultrasound (IVUS)-guided drug-coated balloon angioplasty compared with angiography-guided drug-coated balloon angioplasty among patients with de novo coronary lesions.

Angioplasty 53

Angioplasty Ultrasound Article 53

Med Page Today

SEPTEMBER 5, 2024

(MedPage Today) -- Submaximal balloon angioplasty for symptomatic intracranial atherosclerotic stenosis (ICAS) improved outcomes over aggressive medical management alone, the BASIS trial from China showed. The incidence of the composite of any.

Angioplasty 52

Angioplasty Stenosis Outcomes 52

American College of Cardiology

OCTOBER 29, 2024

The routine use of orbital atherectomy did not improve minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary lesions.

Angioplasty 53

Angioplasty Stent Stents Article 53

Medical Xpress - Cardiology

APRIL 4, 2024

Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally invasive procedure to unclog the arteries that feed the heart.

Angioplasty 97

Angioplasty Stent Stents Research 97

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

Traditional treatments like plain old balloon angioplasty (POBA) have limited success due to high restenosis rates. Drug-coated balloon angioplasty (DCBA) has emerged as a promising alternative, locally delivering antiproliferative drugs like paclitaxel to reduce restenosis.

Angioplasty 52

Angioplasty Peripheral Arterial Disease Outcomes Research 52

Stroke Journal

MARCH 23, 2025

The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis.

Angioplasty 40

Angioplasty Stenosis Coronary Artery Disease Stent 40

American College of Cardiology

JUNE 6, 2024

The ORBITA-2 (Objective Randomized Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina) trial data demonstrate that, in patients with stable angina and ischemia producing coronary stenoses.

Angina 53

Angina Angioplasty Ischemia Article 53

HCPLive

APRIL 29, 2024

Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Angioplasty Stent Stents 111

Journal of Cardiothoracic Surgery

AUGUST 20, 2024

This research evaluates the effect of balloon pulmonary angioplasty (BPA) on cardiac electrophysiological changes in patients with chronic thromboembolic pulmonary hypertension (CTEPH).

Angioplasty 52

Angioplasty Pulmonary Hypertension Electrophysiology 52

American College of Cardiology

OCTOBER 9, 2024

Is balloon angioplasty plus medical management superior to medical management alone in patients with symptomatic intracranial atherosclerotic stenosis?

Angioplasty 45

Angioplasty Stenosis Article 45

Medical Xpress - Cardiology

JANUARY 17, 2024

When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI. By inflating a balloon and potentially placing a stent, they can help blood flow more freely from the heart.

Stent 89

Stent Stents Angioplasty 89

American College of Cardiology

OCTOBER 28, 2024

The goal of the DCB-BIF trial was to assess the efficacy of drug-coated balloon (DCB) angioplasty of residual side branch stenosis in coronary bifurcation lesions treated with a provisional stenting strategy.

Angioplasty 56

Angioplasty Stent Stents Stenosis 56

Journal of Cardiothoracic Surgery

DECEMBER 18, 2024

This study aimed to analyze the safety and mid-term outcomes of a hybrid treatment method combining rotational atherectomy (RA) with drug-coated balloon (DCB) angioplasty in patients with femoropopliteal arter.

Angioplasty 52

Angioplasty Stent Stents Outcomes 52

Med Page Today

OCTOBER 1, 2024

(MedPage Today) -- A look at the feasibility of coronary angiography and angioplasty procedures using the Meta Quest 3 virtual reality (VR) headset. European Heart Journal) FDA approved flurpiridaz F-18 (Flyrcado), a radiotracer for positron.

Angioplasty 103

Angioplasty 103

DAIC

APRIL 11, 2024

The study, called IVUS-DCB, is the first randomized controlled trial to demonstrate the clinical benefits of using IVUS in angioplasty procedures for peripheral artery disease (PAD), a condition in which plaque builds up in arteries in the legs. Half were randomly assigned to receive IVUS plus angiography and half received angiography alone.

Peripheral Arterial Disease 116

Peripheral Arterial Disease Ultrasound Angioplasty Plaque 116

Medical Xpress - Cardiology

NOVEMBER 4, 2024

27 to 30 in Washington, D.C.

Angioplasty 40

Angioplasty Stent Stents 40

Heart BMJ

AUGUST 26, 2024

Balloon pulmonary angioplasty (BPA) is an effective treatment for CTEPH, but the efficacy of BPA in patients with CTEPH with low DLco remains unclear because BPA does not directly address microvascular damage.

Angioplasty 52

Angioplasty Pulmonary Exercise Hypertension 52

HeartRhythm

APRIL 30, 2024

Intramural vein mapping via angioplasty wire can localize such foci, but RFA delivery via angioplasty wire is limited. The most common cause of radiofrequency ablation (RFA) failure is inability to reach intramural foci.

Angioplasty 40

Angioplasty Ablation 40

Circulation

MARCH 7, 2024

Balloon pulmonary angioplasty continues to gain traction as a treatment option for patients with chronic thromboembolic pulmonary disease with and without pulmonary hypertension. Not surprisingly, chronic thromboembolic pulmonary hypertension centers are rapidly initiating balloon pulmonary angioplasty programs.

Angioplasty 45

Angioplasty Pulmonary Hypertension Document 45

Stroke Journal

FEBRUARY 1, 2024

Introduction:Traditional endovascular treatment for acutely symptomatic intracranial atherosclerotic disease (ICAD) includes balloon angioplasty and stenting. Catheter mediated angioplasty (or “Dotter” angioplasty) has been previously described for extracranial carotid and peripheral arteries.

Angioplasty 40

Angioplasty Stenosis Stent Stents 40

JAMA Cardiology

DECEMBER 22, 2024

This narrative review discusses drug-coated balloon angioplasty as an alternative to drug-eluting stent for percutaneous coronary intervention in patients with in-stent restenosis and de novo coronary artery disease.

Coronary Artery Disease 86

Coronary Artery Disease Angioplasty Stent Stents 86

Open Heart

MARCH 3, 2025

Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. Biodegradable polymer DESs (BP-DESs) have been postulated to be superior to durable polymer DESs (DP-DESs) due to their more biocompatible polymer.

Stent 52

Stent Stents Myocardial Infarction Angioplasty 52

American College of Cardiology

SEPTEMBER 2, 2024

A strategy of drug-coated balloon (DCB) angioplasty with rescue stenting did not achieve noninferiority compared with intended drug-eluting stent (DES) deployment for patients with de novo, noncomplex coronary artery lesions, according to finding from the REC-CAGEFREE I trial presented at ESC Congress 2024 in London and simultaneously published in (..)

Angioplasty 40

Angioplasty Stent Stents Article 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Santa Clara, CA, USA) semi compliant balloon adapted from cardiovascular literature which showed a pre‐dilation angioplasty capability in coronary stenotic lesions.MethodsWe performed a retrospective review of prospectively maintained mechanical thrombectomy (MT) databases of 2 comprehensive stroke centers between November 2020, and May 2023.

Angioplasty 40

Angioplasty Stent Stents Stroke 40

DAIC

MARCH 13, 2024

milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty.

Stent 116

Stent Angioplasty Stents Myocardial Infarction 116

American College of Cardiology

FEBRUARY 11, 2025

Calcified coronary lesions are associated with lower procedural success and higher complications with percutaneous coronary intervention. Previous study data have shown improved procedural success with routine use of atherectomy in these patients without meaningful differences in clinical outcomes.

Angioplasty 56

Angioplasty Outcomes Article 56

Becker's Hospital Review - Cardiology

NOVEMBER 7, 2024

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.

Stent 52

Stent Stents Angioplasty Outcomes 52

Med Page Today

MAY 15, 2024

(MedPage Today) -- PARIS -- Antiplatelet de-escalation worked well following drug-coated balloon (DCB) placement for acute coronary syndrome (ACS), according to the first randomized trial on this subject. In REC-CAGEFREE II, the strategy of.

Angioplasty 52

Angioplasty 52

American College of Cardiology

JANUARY 6, 2025

The first successful percutaneous transluminal coronary angioplasty was performed by Andreas Gruentzig, MD, in September 1977.

Angioplasty 68

Angioplasty Article 68

Frontiers in Cardiovascular Medicine

JULY 24, 2024

This review delves into the current therapeutic strategies for CTEPH, including surgical pulmonary endarterectomy (PEA), balloon pulmonary angioplasty (BPA), and targeted pharmacological treatments such as PDE5 inhibitors, endothelin receptor antagonists, sGC stimulators, and prostanoids.

Pulmonary 98

Pulmonary Hypertension Angioplasty Pharmacology 98

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We included articles reporting patients > 18 years old with symptomatic extracranial vertebral artery stenoses due to atherosclerosis treated with stenting (with or without angioplasty). During follow‐up, in‐stent stenosis >50% was observed in 12.8%, and retreatment with either re‐stenting or angioplasty was performed in 10.8%.

Angioplasty 40

Angioplasty Stent Stents Stenosis 40

DAIC

MAY 3, 2024

Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable 9. Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) Due to Long-term Buildup of biological material Causing an Obstruction 8. EMPACT-MI Trial Outcomes Reported at ACC.24: 24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack 10.

Angioplasty 105

Angioplasty Blood Pressure Heart attacks Heart Attack 105

American College of Cardiology

DECEMBER 21, 2023

The goal of the ORBITA-2 trial was to assess the efficacy of percutaneous coronary intervention (PCI) compared with a sham placebo procedure for angina relief among patients with stable angina who were not on background antianginal medication.

Angina 60

Angina Angioplasty Article 60

Stroke Journal

JANUARY 30, 2025

The objective of our study is to identify factors associated with SBIs following middle cerebral artery (MCA) stenting or balloon angioplasty.Methods:We retrospectively reviewed patients who underwent MCA stenting or balloon angioplasty, including those with symptomatic, atherosclerotic MCA stenosis of 50%.

Angioplasty 40

Angioplasty Stent Stents Stenosis 40

Med Page Today

APRIL 30, 2024

(MedPage Today) -- For patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia, drug-eluting stents and drug-coated balloons did not improve amputation-free survival compared with balloon angioplasty alone in the BASIL.

Peripheral Arterial Disease 64

Peripheral Arterial Disease Angioplasty Heart Disease Cancer 64

American College of Cardiology

OCTOBER 29, 2024

The goal of the ECLIPSE trial was to evaluate orbital atherectomy prior to drug-eluting stent (DES) implantation compared with conventional percutaneous coronary intervention (PCI) without atherectomy among patients with calcified coronary lesions.

Angioplasty 53

Angioplasty Stent Stents Article 53